Getinge expands production capacity of DPTE-BetaBag® to the US
Getinge is introducing production of DPTE-BetaBag® at its existing manufacturing site in Merrimack, NH, in the US. With the expansion, Getinge expects to double the production capacity of DPTE-BetaBag® in order to meet the positive growth in the sterile transfer business, primarily driven by increased demand of vaccine production.Getinge is producing the DPTE-BetaBag® in Vendôme, France, since 1998. Customer demand has increased during recent years and Getinge has decided to invest in its existing manufacturing site in Merrimack, US, to meet the demand. The Merrimack site will mirror the